Key Points - Multiple law firms have filed class action lawsuits against Flotek Industries, Inc. - Investors who suffered losses in FTK are encouraged to inquire about securities fraud cases. - Class action lawsuits cover a period between August 3, 2026, and August 17, 2026. - Investors have until October 26, 2026, to file as...
Key Points - Rosen Law Firm reminds Capricor Therapeutics, Inc. investors of important lead plaintiff deadline...
Roth Capital analyst issues BUY recommendation for ANVS on August 27, 2026 10:55PM ET. The previous...
Jiayin Group Inc. (JFIN) - This analysis reviews how the stock price reacted after the last...
Jiayin Group Inc. (JFIN) - This analysis reviews how the stock price reacted during the last...
Jake Fuller from BTIG issued a price target of $35.00 for REAX on 2026-08-27 14:34:27.The adjusted price target was set to $35.00.At the time of the announcement, REAX was trading...
from Lake Street issued a price target of $25.00 for OOMA on 2026-08-27 12:44:54.The adjusted price target was set to $25.00.At the time of the announcement, OOMA was trading at...
from Lake Street issued a price target of $9.00 for VRCA on 2026-08-27 11:57:47.The adjusted price target was set to $9.00.At the time of the announcement, VRCA was trading at...
from Cantor Fitzgerald issued a price target of $26.00 for SLDB on 2026-08-27 11:54:17.The adjusted price target was set to $26.00.At the time of the announcement, SLDB was trading at...
from Industrial Alliance Securities issued a price target of $27.00 for OOMA on 2026-08-27 08:47:51.The adjusted price target was set to $27.00.At the time of the announcement, OOMA was trading...
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
